260 related articles for article (PubMed ID: 21825302)
21. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
Shao J; Liu X; Ly H; Liang Y
J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230
[TBL] [Abstract][Full Text] [Related]
23. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
[TBL] [Abstract][Full Text] [Related]
24. Reverse genetics approaches to combat pathogenic arenaviruses.
de la Torre JC
Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
Bolken TC; Laquerre S; Zhang Y; Bailey TR; Pevear DC; Kickner SS; Sperzel LE; Jones KF; Warren TK; Amanda Lund S; Kirkwood-Watts DL; King DS; Shurtleff AC; Guttieri MC; Deng Y; Bleam M; Hruby DE
Antiviral Res; 2006 Feb; 69(2):86-97. PubMed ID: 16343651
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.
Sleeman K; Stein DA; Tamin A; Reddish M; Iversen PL; Rota PA
Virus Res; 2009 Mar; 140(1-2):49-56. PubMed ID: 19059443
[TBL] [Abstract][Full Text] [Related]
27. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
28. Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.
Moreno H; Grande-Pérez A; Domingo E; Martín V
Viruses; 2012 Nov; 4(11):2786-805. PubMed ID: 23202505
[TBL] [Abstract][Full Text] [Related]
29. The PI3K/Akt pathway contributes to arenavirus budding.
Urata S; Ngo N; de la Torre JC
J Virol; 2012 Apr; 86(8):4578-85. PubMed ID: 22345463
[TBL] [Abstract][Full Text] [Related]
30. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
31. Arenavirus reverse genetics for vaccine development.
Ortiz-Riaño E; Cheng BYH; Carlos de la Torre J; Martínez-Sobrido L
J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194
[TBL] [Abstract][Full Text] [Related]
32. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
Rojek JM; Pasqual G; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
J Virol; 2010 Jan; 84(1):573-84. PubMed ID: 19846507
[TBL] [Abstract][Full Text] [Related]
33. Novel antiviral strategies to combat human Arenavirus infections.
Kunz S; de la Torre JC
Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
[TBL] [Abstract][Full Text] [Related]
34. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication.
Patel D; Opriessnig T; Stein DA; Halbur PG; Meng XJ; Iversen PL; Zhang YJ
Antiviral Res; 2008 Feb; 77(2):95-107. PubMed ID: 17959259
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism.
Spence JS; Melnik LI; Badani H; Wimley WC; Garry RF
J Virol; 2014 Aug; 88(15):8556-64. PubMed ID: 24850726
[TBL] [Abstract][Full Text] [Related]
36. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).
King BR; Hershkowitz D; Eisenhauer PL; Weir ME; Ziegler CM; Russo J; Bruce EA; Ballif BA; Botten J
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539447
[TBL] [Abstract][Full Text] [Related]
37. Superinfection exclusion in BHK-21 cells persistently infected with Junín virus.
Ellenberg P; Linero FN; Scolaro LA
J Gen Virol; 2007 Oct; 88(Pt 10):2730-2739. PubMed ID: 17872526
[TBL] [Abstract][Full Text] [Related]
38. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
Thomas CJ; Casquilho-Gray HE; York J; DeCamp DL; Dai D; Petrilli EB; Boger DL; Slayden RA; Amberg SM; Sprang SR; Nunberg JH
J Biol Chem; 2011 Feb; 286(8):6192-200. PubMed ID: 21159779
[TBL] [Abstract][Full Text] [Related]
39. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
40. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]